Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

WuXi NextCODE Participates in $68 Million DNAnexus Funding

EdiGene Completes $10 Million Round for Gene Editing-based Discovery

MabPlex, a China Biologic CDMO, Closes $59 million Series A

Boehringer Ingelheim Expands Shanghai Biologics CDMO Facility

Thousand Oaks Biopharma Closes $45 Million Series A Funding Round

Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Shanghai , China
March 5-6, 2019

Shanghai , China
March 26-28, 2019